Goshima Y, Kubo T, Misu Y
Br J Pharmacol. 1986 Sep;89(1):229-34. doi: 10.1111/j.1476-5381.1986.tb11139.x.
Effects of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices evoked by electrical field stimulation at 5 Hz were investigated in the absence and presence of p-bromobenzyloxyamine (NSD-1055), a DOPA-decarboxylase inhibitor. In the absence of NSD-1055, L-DOPA produced a facilitation of impulse-evoked release of noradrenaline at 0.1 microM but not at 1 and 10 microM, and had no effect on the spontaneous release. On the other hand, L-DOPA 0.1 to 10 microM dose-dependently increased the spontaneous release of dopamine and the highest concentration only increased the evoked release and tissue content of dopamine. In the presence of NSD-1055 10 microM, the increase in the spontaneous release of dopamine was prevented and L-DOPA produced biphasic regulatory effects on the evoked release of noradrenaline and dopamine, a facilitation at 0.1 microM and an inhibition at 1 microM. The facilitation was antagonized by (-)-propranolol 0.1 microM, but not by the (+)-isomer, whereas the inhibition was antagonized by S-sulpiride 1 nM, but not by the R-isomer. In conclusion, L-DOPA appears to produce biphasic actions on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices, not through its conversion to dopamine but through presynaptic regulatory mechanisms, an inhibition via dopamine receptors at a micromolar concentration and a facilitation via beta-adrenoceptors at the lower concentration.
在存在和不存在多巴脱羧酶抑制剂对溴苄氧胺(NSD - 1055)的情况下,研究了左旋多巴(L - DOPA)对5Hz电场刺激诱发的大鼠下丘脑切片内源性去甲肾上腺素和多巴胺释放的影响。在不存在NSD - 1055时,L - DOPA在0.1μM时促进了去甲肾上腺素的冲动诱发释放,但在1μM和10μM时未促进,且对自发释放无影响。另一方面,0.1至10μM的L - DOPA剂量依赖性地增加了多巴胺的自发释放,最高浓度仅增加了多巴胺的诱发释放和组织含量。在存在10μM NSD - 1055时,多巴胺自发释放的增加被阻止,L - DOPA对去甲肾上腺素和多巴胺的诱发释放产生双相调节作用,在0.1μM时促进,在1μM时抑制。这种促进作用被0.1μM的( - ) - 普萘洛尔拮抗,但不被( + ) - 异构体拮抗,而抑制作用被1nM的S - 舒必利拮抗,但不被R - 异构体拮抗。总之,L - DOPA似乎对大鼠下丘脑切片内源性去甲肾上腺素和多巴胺的释放产生双相作用,不是通过其转化为多巴胺,而是通过突触前调节机制,在微摩尔浓度下通过多巴胺受体抑制,在较低浓度下通过β - 肾上腺素受体促进。